SCHEMBL25260451

SCHEMBL25260451

COc1ccccc1-c1cnc(C(F)(F)F)cc1C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.46
AKR1C2 P52895 1/20 0.46
GPBAR1 Q8TDU6 1/20 0.45
HPGD P15428 5/20 0.44
KDM4E B2RXH2 5/20 0.44
HTT P42858 3/20 0.44
LMNA P02545 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
MITF O75030 1/20 0.44
STAT3 P40763 1/20 0.44
KMT2A Q03164 1/20 0.44
DHODH Q02127 1/20 0.44
ALPL P05186 1/20 0.43
GPR35 Q9HC97 3/20 0.43
ALDH1A1 P00352 4/20 0.41
EIF4E P06730 1/20 0.41
HSD17B10 Q99714 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
MAPK1 P28482 2/20 0.41
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31019085 1.00 AKR1C3 (0.46) AKR1C3AKR1C2GPBAR1HPGDKDM4E
SCHEMBL25262459 0.90 AKR1C3 (0.46) AKR1C3AKR1C2GPBAR1HPGDKDM4E
SCHEMBL25307008 0.89 SDHB (0.46) AKR1C3AKR1C2GPBAR1HPGDKDM4E
SCHEMBL22717518 0.83 DHODH (0.46) AKR1C3AKR1C2HPGDKDM4EHTT
SCHEMBL29574466 0.83 DHODH (0.46) AKR1C3AKR1C2HPGDKDM4EHTT
SCHEMBL17009018 0.81 LCK (0.45) HPGDKDM4ELMNAKMT2AALDH1A1
SCHEMBL31414058 0.80 KDM4E (0.44) AKR1C3AKR1C2HPGDKDM4EHTT
SCHEMBL29574343 0.77 GPR35 (0.46) HPGDKDM4EHTTNPSR1KMT2A
SCHEMBL22717450 0.77 GPR35 (0.46) HPGDKDM4EHTTNPSR1KMT2A
SCHEMBL22732327 0.75 HPGD (0.45) AKR1C3AKR1C2GPBAR1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250122221-A1 SIX-MEMBERED CYCLOTHIAZOLE COMPOUND AND USE THEREOF NANJING ZAIMING PHARMACEUTICAL CO., LTD. (CN) 2025-04-17 US disclosed
EP-4464709-A1 SIX-MEMBERED CYCLOTHIAZOLE COMPOUND AND USE THEREOF Nanjing Zaiming Pharmaceutical Co., Ltd. (CN) 2024-11-20 EP disclosed
WO-2023134739-A1 SIX-MEMBERED CYCLOTHIAZOLE COMPOUND AND USE THEREOF 南京再明医药有限公司 2023-07-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250122221-A1 SIX-MEMBERED CYCLOTHIAZOLE COMPOUND AND USE THEREOF POLRMT, POLQ, POLH AKR1C3 2528/4885AKR1C2 2054/4885GPBAR1 2665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.